NeuroPace, Inc.
NPCE · NASDAQ
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Market Cap | $341,618 | $366,094 | $386,900 | $334,746 |
| - Cash | $20,648 | $22,857 | $27,019 | $13,430 |
| + Debt | $71,181 | $71,519 | $73,152 | $73,338 |
| Enterprise Value | $392,151 | $414,756 | $433,033 | $394,654 |
| Revenue | $27,354 | $23,520 | $22,524 | $21,466 |
| % Growth | 16.3% | 4.4% | 4.9% | – |
| Gross Profit | $21,168 | $18,132 | $17,342 | $16,188 |
| % Margin | 77.4% | 77.1% | 77% | 75.4% |
| EBITDA | -$2,464 | -$6,115 | -$3,974 | -$2,607 |
| % Margin | -9% | -26% | -17.6% | -12.1% |
| Net Income | -$3,496 | -$8,651 | -$6,589 | -$5,250 |
| % Margin | -12.8% | -36.8% | -29.3% | -24.5% |
| EPS Diluted | -0.11 | -0.26 | -0.21 | -0.18 |
| % Growth | 57.7% | -23.8% | -16.7% | – |
| Operating Cash Flow | -$1,944 | -$2,086 | -$7,482 | -$4,797 |
| Capital Expenditures | -$30 | -$168 | -$37 | -$39 |
| Free Cash Flow | -$1,974 | -$2,254 | -$7,519 | -$4,836 |